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Background
The description of complex regulatory immunologic path-
ways represents a major difficulty during preclinical test-
ing. Animal models are widely used for this purpose. In
the study described herein, a human in vitro allergy model
was established providing an alternative method to investi-
gate allergy driven immune responses. The model should
be able to show the influence of cellular components as
i.e. plasmacytoid dendritic cells (pDC) or drug candidates.
This might allow the avoidance of animal experiments and
relates more closely to the human situation. For example,
plasmacytoid dendritic cells (pDC) representing a DC sub-
population with major immunologic regulatory functions,
were investigated to show a clear analogy to the in vivo
situation in the model.
Material and methods
Antigen-presenting cells were generated from CD14-posi-
tive monocytes obtained from whole blood of healthy or
allergic donors. On day 5, APC were stimulated with
house dust mite extract (HDM). On day 7, cells were har-
vested and DC were co-cultured with autologous CD4+
lymphocytes (ratio 1:10) in the presence of allergen with
or without pDC or a immunomodulatory compound.
Alternatively, PBMC were isolated from whole blood of
healthy donors and stimulated with HDM ± pDC. The
effects of pDC on the allergen-induced T cell proliferation
were analyzed by ³H-thymidine incorporation. Cytokine
secretion was measured in cell culture supernatants.
Results
The generated and HDM-pulsed APC induced strong
proliferation of the cocultured CD4+ lymphocytes com-
pared to the unpulsed APC. The presence of pDC in the
cocultures inhibited this proliferative response by about
50%. Likewise, the proliferation of HDM-stimulated
PBMC was dose-dependently reduced by pDC, with the
highest pDC dose nearly completely abolishing the aller-
gen induced proliferation showing a significant deregu-
lating functionality.
Conclusions
An allergen-specific T cell immune response can repro-
ducibly be performed using the human in vitro allergy
model. The presence of pDC in this model clearly
reduced the allergen-induced immune response, demon-
strating the regulatory properties of this DC subpopula-
tion depending on the stimulatory APC to pDC cell
ratio. Hence, this model enables to mimic allergen-spe-
cific immune responses and furthermore regulatory
mechanisms. In the future, this model thus might be
applicable for efficacy testing of potential immunoregu-
latory cellular therapeutics or biomolecules with the
advantages of avoiding animal experiments and enabling
greater predictivity for the human situation.
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